Loading…

Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma

Cancer cachexia is a syndrome of weight loss, muscle wasting, fatigue, and anorexia that occurs in patients with advanced or recurrent solid tumor disease. Tumor necrosis factor‐alpha (TNFα) and prostaglandin E2 (PGE2) have been implicated in the biology of cachexia and serve as possible targets for...

Full description

Saved in:
Bibliographic Details
Published in:Research in nursing & health 2005-02, Vol.28 (1), p.48-55
Main Authors: Graves, Erin, Hitt, Andrew, Pariza, Michael W., Cook, Mark E., McCarthy, Donna O.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4182-4f023aef0ed98b795716f4f474026d6eeec0b5063512acbb1ab35532dd3bfdd93
cites cdi_FETCH-LOGICAL-c4182-4f023aef0ed98b795716f4f474026d6eeec0b5063512acbb1ab35532dd3bfdd93
container_end_page 55
container_issue 1
container_start_page 48
container_title Research in nursing & health
container_volume 28
creator Graves, Erin
Hitt, Andrew
Pariza, Michael W.
Cook, Mark E.
McCarthy, Donna O.
description Cancer cachexia is a syndrome of weight loss, muscle wasting, fatigue, and anorexia that occurs in patients with advanced or recurrent solid tumor disease. Tumor necrosis factor‐alpha (TNFα) and prostaglandin E2 (PGE2) have been implicated in the biology of cachexia and serve as possible targets for treatment of this condition. Conjugated linoleic acid (CLA) is a polyunsaturated fatty acid that alters the synthesis of PGE2 and reduces the negative effects of TNF on body weight of healthy mice. We hypothesized that a diet supplemented with .5% CLA might reduce muscle wasting in mice bearing the colon‐26 adenocarcinoma, an animal model of cancer cachexia. CLA preserved gastrocnemius muscle mass and reduced TNF receptors in muscle of tumor‐bearing mice. These data suggest that CLA may preserve muscle mass by reducing the catabolic effects of TNF on skeletal muscle. © 2004 Wiley Periodicals, Inc. Res Nurs Health 28:48–55, 2005
doi_str_mv 10.1002/nur.20052
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67339254</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>814036001</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4182-4f023aef0ed98b795716f4f474026d6eeec0b5063512acbb1ab35532dd3bfdd93</originalsourceid><addsrcrecordid>eNp10MFu1DAQBmALgei2cOAFkIVUJA5px3bsbI5oVQpiWySgojfLsSdbL4m92Emhb0-WXahUiZMv3_wz_gl5weCEAfDTMKYTDiD5IzJjUM8LXsL1YzIDpqBQ85odkMOc1wCMSc6ekgMmFZcVYzNys4hhPa7MgI52PsQOvaXGekc3CTOmW8x0ZfKQog3Y-zHTfsy2Q9qbnKkPtPcWaYMm-bCiww1SG7sYCq6ocRiiNclOsb15Rp60psv4fP8ekat3Z18X74vlp_MPi7fLwpZszouyBS4MtoCunjdVPV2p2rItqxK4cgoRLTQSlJCMG9s0zDRCSsGdE03rXC2OyOtd7ibFHyPmQfc-W-w6EzCOWatKiJrLcoKvHsB1HFOYbtOc80pVvIYJvdkhm2LOCVu9Sb436U4z0Nvu9dS9_tP9ZF_uA8emR3cv92VP4HgPTLama5MJ1ud7p6RQSm6Xnu7cT9_h3f836surz39XF7sJnwf89W_CpO_b_1ZSf7s818uSXavFl4_6QvwGWsiqhw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222767290</pqid></control><display><type>article</type><title>Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma</title><source>Applied Social Sciences Index &amp; Abstracts (ASSIA)</source><source>Wiley</source><creator>Graves, Erin ; Hitt, Andrew ; Pariza, Michael W. ; Cook, Mark E. ; McCarthy, Donna O.</creator><creatorcontrib>Graves, Erin ; Hitt, Andrew ; Pariza, Michael W. ; Cook, Mark E. ; McCarthy, Donna O.</creatorcontrib><description>Cancer cachexia is a syndrome of weight loss, muscle wasting, fatigue, and anorexia that occurs in patients with advanced or recurrent solid tumor disease. Tumor necrosis factor‐alpha (TNFα) and prostaglandin E2 (PGE2) have been implicated in the biology of cachexia and serve as possible targets for treatment of this condition. Conjugated linoleic acid (CLA) is a polyunsaturated fatty acid that alters the synthesis of PGE2 and reduces the negative effects of TNF on body weight of healthy mice. We hypothesized that a diet supplemented with .5% CLA might reduce muscle wasting in mice bearing the colon‐26 adenocarcinoma, an animal model of cancer cachexia. CLA preserved gastrocnemius muscle mass and reduced TNF receptors in muscle of tumor‐bearing mice. These data suggest that CLA may preserve muscle mass by reducing the catabolic effects of TNF on skeletal muscle. © 2004 Wiley Periodicals, Inc. Res Nurs Health 28:48–55, 2005</description><identifier>ISSN: 0160-6891</identifier><identifier>EISSN: 1098-240X</identifier><identifier>DOI: 10.1002/nur.20052</identifier><identifier>PMID: 15625711</identifier><identifier>CODEN: RNHEDO</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Adenocarcinoma - complications ; Adenocarcinoma - pathology ; Animals ; Biological and medical sciences ; Body Weight - drug effects ; Cachexia - drug therapy ; Cachexia - etiology ; Cancer ; cancer cachexia ; colon-26 adenocarcinoma ; Colonic Neoplasms - complications ; Colonic Neoplasms - pathology ; conjugated linoleic acid ; Disease Models, Animal ; Enzyme-Linked Immunosorbent Assay ; Fatty acids ; Female ; Linoleic Acids, Conjugated - pharmacology ; Medical sciences ; Mice ; Miscellaneous ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - metabolism ; Muscular system ; Neoplasms, Experimental - complications ; Neoplasms, Experimental - pathology ; Nursing ; Proteins ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Rodents ; Tumor Cells, Cultured ; tumor necrosis factor ; Tumors</subject><ispartof>Research in nursing &amp; health, 2005-02, Vol.28 (1), p.48-55</ispartof><rights>Copyright © 2004 Wiley Periodicals, Inc.</rights><rights>2005 INIST-CNRS</rights><rights>(c) 2004 Wiley Periodicals, Inc.</rights><rights>Copyright John Wiley and Sons, Limited Feb 2005</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4182-4f023aef0ed98b795716f4f474026d6eeec0b5063512acbb1ab35532dd3bfdd93</citedby><cites>FETCH-LOGICAL-c4182-4f023aef0ed98b795716f4f474026d6eeec0b5063512acbb1ab35532dd3bfdd93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925,30999</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16536650$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15625711$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Graves, Erin</creatorcontrib><creatorcontrib>Hitt, Andrew</creatorcontrib><creatorcontrib>Pariza, Michael W.</creatorcontrib><creatorcontrib>Cook, Mark E.</creatorcontrib><creatorcontrib>McCarthy, Donna O.</creatorcontrib><title>Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma</title><title>Research in nursing &amp; health</title><addtitle>Res. Nurs. Health</addtitle><description>Cancer cachexia is a syndrome of weight loss, muscle wasting, fatigue, and anorexia that occurs in patients with advanced or recurrent solid tumor disease. Tumor necrosis factor‐alpha (TNFα) and prostaglandin E2 (PGE2) have been implicated in the biology of cachexia and serve as possible targets for treatment of this condition. Conjugated linoleic acid (CLA) is a polyunsaturated fatty acid that alters the synthesis of PGE2 and reduces the negative effects of TNF on body weight of healthy mice. We hypothesized that a diet supplemented with .5% CLA might reduce muscle wasting in mice bearing the colon‐26 adenocarcinoma, an animal model of cancer cachexia. CLA preserved gastrocnemius muscle mass and reduced TNF receptors in muscle of tumor‐bearing mice. These data suggest that CLA may preserve muscle mass by reducing the catabolic effects of TNF on skeletal muscle. © 2004 Wiley Periodicals, Inc. Res Nurs Health 28:48–55, 2005</description><subject>Adenocarcinoma - complications</subject><subject>Adenocarcinoma - pathology</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Body Weight - drug effects</subject><subject>Cachexia - drug therapy</subject><subject>Cachexia - etiology</subject><subject>Cancer</subject><subject>cancer cachexia</subject><subject>colon-26 adenocarcinoma</subject><subject>Colonic Neoplasms - complications</subject><subject>Colonic Neoplasms - pathology</subject><subject>conjugated linoleic acid</subject><subject>Disease Models, Animal</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Fatty acids</subject><subject>Female</subject><subject>Linoleic Acids, Conjugated - pharmacology</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Miscellaneous</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Muscular system</subject><subject>Neoplasms, Experimental - complications</subject><subject>Neoplasms, Experimental - pathology</subject><subject>Nursing</subject><subject>Proteins</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Rodents</subject><subject>Tumor Cells, Cultured</subject><subject>tumor necrosis factor</subject><subject>Tumors</subject><issn>0160-6891</issn><issn>1098-240X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNp10MFu1DAQBmALgei2cOAFkIVUJA5px3bsbI5oVQpiWySgojfLsSdbL4m92Emhb0-WXahUiZMv3_wz_gl5weCEAfDTMKYTDiD5IzJjUM8LXsL1YzIDpqBQ85odkMOc1wCMSc6ekgMmFZcVYzNys4hhPa7MgI52PsQOvaXGekc3CTOmW8x0ZfKQog3Y-zHTfsy2Q9qbnKkPtPcWaYMm-bCiww1SG7sYCq6ocRiiNclOsb15Rp60psv4fP8ekat3Z18X74vlp_MPi7fLwpZszouyBS4MtoCunjdVPV2p2rItqxK4cgoRLTQSlJCMG9s0zDRCSsGdE03rXC2OyOtd7ibFHyPmQfc-W-w6EzCOWatKiJrLcoKvHsB1HFOYbtOc80pVvIYJvdkhm2LOCVu9Sb436U4z0Nvu9dS9_tP9ZF_uA8emR3cv92VP4HgPTLama5MJ1ud7p6RQSm6Xnu7cT9_h3f836surz39XF7sJnwf89W_CpO_b_1ZSf7s818uSXavFl4_6QvwGWsiqhw</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>Graves, Erin</creator><creator>Hitt, Andrew</creator><creator>Pariza, Michael W.</creator><creator>Cook, Mark E.</creator><creator>McCarthy, Donna O.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>200502</creationdate><title>Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma</title><author>Graves, Erin ; Hitt, Andrew ; Pariza, Michael W. ; Cook, Mark E. ; McCarthy, Donna O.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4182-4f023aef0ed98b795716f4f474026d6eeec0b5063512acbb1ab35532dd3bfdd93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adenocarcinoma - complications</topic><topic>Adenocarcinoma - pathology</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Body Weight - drug effects</topic><topic>Cachexia - drug therapy</topic><topic>Cachexia - etiology</topic><topic>Cancer</topic><topic>cancer cachexia</topic><topic>colon-26 adenocarcinoma</topic><topic>Colonic Neoplasms - complications</topic><topic>Colonic Neoplasms - pathology</topic><topic>conjugated linoleic acid</topic><topic>Disease Models, Animal</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Fatty acids</topic><topic>Female</topic><topic>Linoleic Acids, Conjugated - pharmacology</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Miscellaneous</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Muscular system</topic><topic>Neoplasms, Experimental - complications</topic><topic>Neoplasms, Experimental - pathology</topic><topic>Nursing</topic><topic>Proteins</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Rodents</topic><topic>Tumor Cells, Cultured</topic><topic>tumor necrosis factor</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Graves, Erin</creatorcontrib><creatorcontrib>Hitt, Andrew</creatorcontrib><creatorcontrib>Pariza, Michael W.</creatorcontrib><creatorcontrib>Cook, Mark E.</creatorcontrib><creatorcontrib>McCarthy, Donna O.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index &amp; Abstracts (ASSIA)</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Research in nursing &amp; health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Graves, Erin</au><au>Hitt, Andrew</au><au>Pariza, Michael W.</au><au>Cook, Mark E.</au><au>McCarthy, Donna O.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma</atitle><jtitle>Research in nursing &amp; health</jtitle><addtitle>Res. Nurs. Health</addtitle><date>2005-02</date><risdate>2005</risdate><volume>28</volume><issue>1</issue><spage>48</spage><epage>55</epage><pages>48-55</pages><issn>0160-6891</issn><eissn>1098-240X</eissn><coden>RNHEDO</coden><abstract>Cancer cachexia is a syndrome of weight loss, muscle wasting, fatigue, and anorexia that occurs in patients with advanced or recurrent solid tumor disease. Tumor necrosis factor‐alpha (TNFα) and prostaglandin E2 (PGE2) have been implicated in the biology of cachexia and serve as possible targets for treatment of this condition. Conjugated linoleic acid (CLA) is a polyunsaturated fatty acid that alters the synthesis of PGE2 and reduces the negative effects of TNF on body weight of healthy mice. We hypothesized that a diet supplemented with .5% CLA might reduce muscle wasting in mice bearing the colon‐26 adenocarcinoma, an animal model of cancer cachexia. CLA preserved gastrocnemius muscle mass and reduced TNF receptors in muscle of tumor‐bearing mice. These data suggest that CLA may preserve muscle mass by reducing the catabolic effects of TNF on skeletal muscle. © 2004 Wiley Periodicals, Inc. Res Nurs Health 28:48–55, 2005</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>15625711</pmid><doi>10.1002/nur.20052</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0160-6891
ispartof Research in nursing & health, 2005-02, Vol.28 (1), p.48-55
issn 0160-6891
1098-240X
language eng
recordid cdi_proquest_miscellaneous_67339254
source Applied Social Sciences Index & Abstracts (ASSIA); Wiley
subjects Adenocarcinoma - complications
Adenocarcinoma - pathology
Animals
Biological and medical sciences
Body Weight - drug effects
Cachexia - drug therapy
Cachexia - etiology
Cancer
cancer cachexia
colon-26 adenocarcinoma
Colonic Neoplasms - complications
Colonic Neoplasms - pathology
conjugated linoleic acid
Disease Models, Animal
Enzyme-Linked Immunosorbent Assay
Fatty acids
Female
Linoleic Acids, Conjugated - pharmacology
Medical sciences
Mice
Miscellaneous
Muscle, Skeletal - drug effects
Muscle, Skeletal - metabolism
Muscular system
Neoplasms, Experimental - complications
Neoplasms, Experimental - pathology
Nursing
Proteins
Public health. Hygiene
Public health. Hygiene-occupational medicine
Rodents
Tumor Cells, Cultured
tumor necrosis factor
Tumors
title Conjugated linoleic acid preserves gastrocnemius muscle mass in mice bearing the colon-26 adenocarcinoma
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T23%3A18%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Conjugated%20linoleic%20acid%20preserves%20gastrocnemius%20muscle%20mass%20in%20mice%20bearing%20the%20colon-26%20adenocarcinoma&rft.jtitle=Research%20in%20nursing%20&%20health&rft.au=Graves,%20Erin&rft.date=2005-02&rft.volume=28&rft.issue=1&rft.spage=48&rft.epage=55&rft.pages=48-55&rft.issn=0160-6891&rft.eissn=1098-240X&rft.coden=RNHEDO&rft_id=info:doi/10.1002/nur.20052&rft_dat=%3Cproquest_cross%3E814036001%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4182-4f023aef0ed98b795716f4f474026d6eeec0b5063512acbb1ab35532dd3bfdd93%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=222767290&rft_id=info:pmid/15625711&rfr_iscdi=true